Skip to main content
Caplight Logo









Minomic International

Minomic International

Private
SydneyHealthcare & Life Scienceshttps://minomic.com/

Last Round

Grant

Feb 2, 2022

Total Funding Raised

$1.09M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Minomic International is a biotechnology company that develops non-invasive diagnostic tests for cancer, including its flagship MiCheck® Prostate test for the risk assessment of clinically significant prostate cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

prostate cancer diagnosticblood-based diagnosticliquid biopsycancer biomarkerprostate cancer screeningmonoclonal antibodyclinical decision supportprecision oncologydiagnostic algorithmprostate-specific antigenPSACLIA labcancer imagingbiotech diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Minomic International Comparables

Compare Minomic International with similar companies based on industry and business-model similarity.

Minomic International comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LynxDx
84%
A3P Biomedical
83%
NucleoBio Corp
82%

Minomic International Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 2, 2022
GrantNov 1, 2015
VC RoundMar 8, 2012

Minomic International Investors

Notable investors and investment history

Minomic International investors
InvestorRounds
National Health and Medical Research CouncilGrant
Australian Research CouncilGrant
AMGCGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 14, 2026

    Monthly visitors grew 169% MoM, reaching 2K.

  • Apr 18, 2026

    Monthly visitors grew 542% MoM, from 114 to 732.

Minomic International Filings

Explore SEC and related filing metadata, where available.

Minomic International filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Minomic International's valuation, stock price, and market status.

Is Minomic International a public or private company?

Minomic International is a private company.

What is the current stock price of Minomic International?

Minomic International is a private company with no public stock price. No recent secondary market data is available.

How much is Minomic International worth (valuation)?

Valuation information for Minomic International is not publicly available.

Can I buy Minomic International stock?

Minomic International shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Minomic International's last funding round?

Minomic International's most recent funding round was Grant on February 2, 2022.

Who are the main investors in Minomic International?

Key investors in Minomic International include National Health and Medical Research Council, Australian Research Council, AMGC.

Will Minomic International IPO soon?

No public IPO plans have been announced for Minomic International.

How can I track Minomic International secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Minomic International's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSydney
Employee Range13
Year Founded2000
Last FundingFeb 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?